Trial Profile
A Population-Based Cohort Study assessing Risk of Cardiovascular Events in Older Patients with Gout Initiating Febuxostat Versus Allopurinol
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2017
Price :
$35
*
At a glance
- Drugs Allopurinol (Primary) ; Febuxostat (Primary)
- Indications Gout
- Focus Therapeutic Use
- 18 Dec 2017 New trial record
- 08 Nov 2017 Results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting